BCWORLD PHARM Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for BCWORLD PHARM.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 33.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Investors Shouldn't Be Too Comfortable With BCWORLD PHARM's (KOSDAQ:200780) Earnings
Mar 18
BCWORLD PHARM (KOSDAQ:200780) Seems To Be Using A Lot Of Debt
Mar 01Does The Market Have A Low Tolerance For BCWORLD PHARM. Co., Ltd.'s (KOSDAQ:200780) Mixed Fundamentals?
Feb 09
Is BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780) A Good Dividend Stock?
Jan 25If You Had Bought BCWorld Pharm (KOSDAQ:200780) Stock A Year Ago, You Could Pocket A 75% Gain Today
Jan 11Do Insiders Own Lots Of Shares In BCWorld Pharm Co., Ltd. (KOSDAQ:200780)?
Dec 26Are BCWorld Pharm's (KOSDAQ:200780) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 08Is BCWorld Pharm (KOSDAQ:200780) A Risky Investment?
Nov 18In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as BCWORLD PHARM has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 72,884 | -8,075 | 4,591 | 7,185 | N/A |
| 6/30/2024 | 72,959 | -6,897 | 4,541 | 7,289 | N/A |
| 3/31/2024 | 72,195 | 859 | 6,329 | 9,326 | N/A |
| 12/31/2023 | 75,111 | 2,634 | 8,229 | 10,938 | N/A |
| 9/30/2023 | 76,056 | 6,240 | 9,962 | 13,879 | N/A |
| 6/30/2023 | 76,213 | 5,651 | 6,757 | 10,549 | N/A |
| 3/31/2023 | 76,040 | 481 | 4,530 | 9,594 | N/A |
| 12/31/2022 | 72,703 | 281 | 619 | 6,883 | N/A |
| 9/30/2022 | 68,918 | 255 | -9,240 | 1,469 | N/A |
| 6/30/2022 | 66,489 | -644 | -12,288 | 2,717 | N/A |
| 3/31/2022 | 63,383 | -2,944 | -17,649 | -2,572 | N/A |
| 12/31/2021 | 62,079 | -1,843 | -19,266 | -620 | N/A |
| 9/30/2021 | 59,217 | -8,508 | -14,908 | -1,183 | N/A |
| 6/30/2021 | 57,763 | -6,032 | -13,577 | -8,405 | N/A |
| 3/31/2021 | 57,071 | -1,956 | -14,431 | -5,022 | N/A |
| 12/31/2020 | 57,030 | -1,580 | -13,099 | -5,502 | N/A |
| 9/30/2020 | 56,434 | -2,450 | -11,078 | 8,902 | N/A |
| 6/30/2020 | 56,034 | -1,392 | -13,270 | 9,815 | N/A |
| 3/31/2020 | 54,135 | -1,972 | -7,592 | 11,905 | N/A |
| 12/31/2019 | 51,497 | -1,553 | -8,935 | 12,110 | N/A |
| 9/30/2019 | 51,440 | 5,011 | -21,457 | -783 | N/A |
| 6/30/2019 | 52,492 | 4,761 | -20,311 | 6,948 | N/A |
| 3/31/2019 | 53,823 | 5,024 | -27,232 | 4,464 | N/A |
| 12/31/2018 | 54,792 | 4,993 | -25,004 | 5,287 | N/A |
| 9/30/2018 | 54,722 | 7,777 | -13,125 | 6,710 | N/A |
| 6/30/2018 | 53,044 | 8,124 | N/A | 5,265 | N/A |
| 3/31/2018 | 51,008 | 8,000 | N/A | 7,599 | N/A |
| 12/31/2017 | 50,207 | 8,083 | N/A | 7,900 | N/A |
| 12/31/2016 | 45,658 | 6,475 | N/A | 244 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if A200780's forecast earnings growth is above the savings rate (2.7%).
Earnings vs Market: Insufficient data to determine if A200780's earnings are forecast to grow faster than the KR market
High Growth Earnings: Insufficient data to determine if A200780's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if A200780's revenue is forecast to grow faster than the KR market.
High Growth Revenue: Insufficient data to determine if A200780's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if A200780's Return on Equity is forecast to be high in 3 years time